Disc Medicine (IRON) Current Assets (2020 - 2026)
Disc Medicine's (IRON) quarterly Current Assets came in at $747.5 million in Q1 2026, up 5.93% year-on-year from $705.6 million in Q1 2025, and down 7.02% on a QoQ basis from $803.9 million in Q4 2025.
Disc Medicine (IRON) Current Assets (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Current Assets data on file, last reported at $747.5 million in Q1 2026.
- On a quarterly basis, Current Assets rose 5.93% year-over-year to $747.5 million in Q1 2026; TTM through Mar 2026 was $747.5 million, a 5.93% increase from a year earlier, with the FY2025 full-year figure at $803.9 million, up 62.86% from the prior year.
- Current Assets for Q1 2026 stood at $747.5 million, down from $803.9 million in the prior quarter.
- Over the last five years, Current Assets for IRON reached as high as $803.9 million in Q4 2025 and fell as low as $104.7 million in Q3 2022.
- Historically, Current Assets has averaged $429.2 million across 5 years, with a median of $381.7 million in 2023.
- Across the five-year window, Current Assets slumped 34.22% in 2022 and jumped 257.59% in 2023, its largest moves.
- Year by year, Current Assets stood at $198.5 million in 2022, then jumped by 84.22% to $365.7 million in 2023, then surged by 34.99% to $493.6 million in 2024, then surged by 62.86% to $803.9 million in 2025, then fell by 7.02% to $747.5 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $747.5 million in Q1 2026, $803.9 million in Q4 2025, and $627.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | 747.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747.46 Mn |
| Dec 31, 2025 | 803.90 Mn |
| Sep 30, 2025 | 627.17 Mn |
| Jun 30, 2025 | 661.59 Mn |
| Mar 31, 2025 | 705.60 Mn |
| Dec 31, 2024 | 493.62 Mn |
| Sep 30, 2024 | 493.15 Mn |
| Jun 30, 2024 | 508.24 Mn |
| Mar 31, 2024 | 351.95 Mn |
| Dec 31, 2023 | 365.66 Mn |
| Sep 30, 2023 | 374.26 Mn |
| Jun 30, 2023 | 381.73 Mn |
| Mar 31, 2023 | 242.14 Mn |
| Dec 31, 2022 | 198.49 Mn |
| Sep 30, 2022 | 104.66 Mn |
| Jun 30, 2022 | 113.13 Mn |
| Mar 31, 2022 | 124.07 Mn |
| Dec 31, 2021 | 90.48 Mn |
| Sep 30, 2021 | 154.80 Mn |
| Jun 30, 2021 | 171.31 Mn |